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Analysis of the mechanisms of cell-mediated immunity by the passive transfer 
of immune cells to appropriate recipients remains one of the most powerful tools 
in the field of immunobiology. Indeed, the first evidence that hypersensitivity to 
tuberculin protein was mediated by lymphoid cells was obtained by the passive 
transfer  of such cells from immune guinea pigs to normal recipients, and  the 
subsequent elicitation of a  hypersensitivity reaction in the skin after tuberculin 
challenge  (1).  However,  although  the  adoptive  transfer  of such  delayed-type 
hypersensitivity reactions  is  readily  achieved  and  hence  commonplace in  the 
literature,  it  has  proved  to  be  much  more  difficult  to  adequately  transfer 
protective immunity against nonacute bacterial infections, for example tubercu- 
losis,  which  are  characterized  by  progressive  growth  of the  organism over  a 
number of weeks (2-4). 
Although it has been shown that acquired immunity to tuberculosis infection 
is cell mediated (5, 6), the precise mechanisms underlying the generation of such 
immunity still remains largely undefined. For example, the relationship between 
the generation of protective immunity, and the generation of cells that possess 
the capacity to elicit delayed-type hypersensitivity reactions to tuberculin, remains 
controversial. The exact nature of this relationship takes on added importance 
with the failure of the recent bacillus Calmette-Gu~rin (BCG) ~ vaccine trial  in 
Southern India (7) in which the immunized individuals expressed an enhanced 
ability  to  respond  to  purified  protein  derivative  but  showed  no  evidence  of 
resistance to subsequent infection. Clearly, therefore, the relationship between 
skin hypersensitivity reactions and the generation of protective immunity after 
vaccination procedures should be more rigorously explored. The present report 
describes  an  attempt  to  develop an  improved  model  of virulent  tuberculosis 
infection permitting the study of acquired immunity to the organism while the 
course of the infectious process was followed in vivo. The experiments described 
in this report were based on the premise that, if an adequate model of adoptive 
immunotherapy against  virulent  tuberculosis  infection  (both  intravenous  and 
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aerosol)  can  be  constructed,  then  such  a  model  would  serve  to  facilitate  the 
analysis of the nature and kinetics of the acquired immune response that develops. 
The  main  purpose  of the  present  report,  however,  is  to  initially  show  that 
passive transfer of protective immunity to virulent tuberculosis infection can be 
readily  achieved,  provided  that  recipient  mice  are  rendered  T  cell-deficient 
before an infusion of donor immune cells.  Moreover, it will confirm the obser- 
vations of Lefford (6) who presented evidence indicating that the expression of 
protective immunity in such recipients is mediated by a  population of sensitized 
T  lymphocytes  that  are  acquired  in  the  donor  animals  in  response  to  the 
tuberculous infection. 
Materials and  Methods 
Mice.  B6D2 (C57BL/6 × DBA/2)F~ and AB6 (A/Tru × C57BL/6)F~ hybrid mice of 
either sex were used when they were between 8 and  12 wk old. All  mice were supplied 
by the Trudeau Animal Breeding Facility. 
Bacteria.  Mycobacterium  boris BCG (BCG Pasteur, Trudeau Mycobacterium Collection 
[TMC]  strain  1011)  was  grown  in  modified Sauton's  medium (8)  and  stored  in  1-ml 
ampules at -70 °C. Mycobacterium  tuberculosis, strain H37Rv (TMC 102) and Erdman (TMC 
107) were grown in Proskauer and Beck liquid medium. Dispersed cultures were obtained 
by the addition to the medium of 0.05% Tween 80, and were stored as above. 
Intravenous  Infection.  Stored  ampules  were  thawed  and  briefly sonicated  (5  s),  and 
bacteria diluted appropriately in cold, sterile, phosphate-buffered saline (PBS). Mice were 
infected intravenously with an inoculum of 0.2 ml of the bacterial suspension via a lateral 
tail vein. 
Aerosol Infection.  Mice were exposed to aerosol infections using a  Middlebrook Air- 
borne Infection Apparatus (Tri-R Instruments, Inc., Rockville Centre NY). The nebulizer 
compartment was filled with  10 ml of M. tuberculosis H37Rv in PBS at a concentration of 
~5 x  108 ml-I; this procedure deposited ~  104 viable bacteria in the lungs over a 30 min 
exposure period. 
Immune Donor Mice.  Donor animals were immunized by intravenous infection with 10 ~ 
viable BCG or  105 viable M.  tuberculosis  Erdman. After  15 or 20 d, respectively, spleen 
cells were harvested from these mice and used in passive cell-transfer experiments. These 
time points  were  chosen  since  they  were  associated  with  the  cessation  of progressive 
proliferation of the infectious organism in the spleens and livers of these mice, and hence 
indicated the presence within the animal of the emergence of an acquired host response. 
Spleen  Cell Preparations.  Prior to their use in passive cell transfers, spleen cell prepa- 
rations  were  treated  as  follows.  Single-cell  suspensions  were  prepared  from  spleens 
harvested asceptically from donor animals and washed and resuspended in RPMI  1640 
medium supplemented with  1 mM glutamine and  2%  heat-inactivated fetal calf serum 
(FCS).  Depletion of the bacterial load within the infected spleen cells was carried out by 
incubating cells (5 ×  107 ml  -~) in sterile plastic dishes (4030; Lab-Tek, Naperville, IL) for 
45 min at 37°C.  Nonadherent cells were removed by washing. The cell suspension was 
then enriched for T  cells by the procedure of Mage et al. (9) which depletes B cells by 
adherence to plastic dishes coated with antisera to mouse immunoglobulin. Plastic dishes 
(4030; Lab-Tek) were coated with goat anti-mouse IgG (Cappel Laboratories Inc. Coch- 
ranville,  PA)  by adding  20  ml of 0.05  M  Tris-HCl buffer, pH  9.5,  containing  20  #g 
antibody ml  -~ and incubating dishes at 25°C for 25 min. Unbound antibody was washed 
away with cold PBS. Spleen cells were added in a volume of 20 ml RPMI plus 2% FCS (2 
×  10 v cells  ml  -~) and  incubated  at 4°C  for 45  min.  Unattached  cells were  harvested, 
washed, and resuspended in cold PBS containing 1% FCS. 
Passive Cell Transfers.  Unless indicated, age- and sex-matched syngeneic recipient mice 
were infused intravenously with  8  ×  107  nonadherent  T  cell-enriched spleen  cells sus- 
pended  in  0.8  ml  PBS  plus  1%  FCS.  A  series of preliminary titrations  (I.  M.  Orme, 
unpublished data) determined that this number of immune cells possessed the capacity to 76  IMMUNITY  TO  MYCOBACTERIUM  TUBERCULOSIS 
transfer detectable levels of protection to appropriate recipients. In the case of intravenous 
rechallenge experiments, recipient animals were infused with T  cell-enriched spleen cells 
from  mice  infected  with M.  tuberculosis  Erdman  20  d  earlier;  1-2  h  later  they  were 
challenged intravenously with  10~-10 n viable Erdman.  In aerosol experiments,  spleen 
cells from mice infected with BCG  14-16 d earlier were infused into recipients within 24 
h of the aerosol exposure to M. tuberculosis. 
Enumeration of Bacteria.  Numbers of viable bacteria in given organs were determined 
by plating suitable dilutions of organ homogenates in cold saline Middlebrook 7H 10 agar 
(Difco Laboratories Inc., Detroit, MI) and counting colony formation after incubation for 
20 d at 37°C. For each time point, four to five animals were sacrificed; data is expressed 
as the log,0 mean  number  of viable organisms per organ  (standard error of the  mean 
always <18%). 
T  Cell-deficient  Test  Recipients.  Mice  were  rendered  T  cell-deficient by  one  of two 
methods: (a) mice were thymectomized at 4 wk of age and 7 d  later received 900 rad of 
whole body gamma irradiation delivered by a  ]~TCe irradiator at a dose rate of 29.5 rad/ 
rain. Mice were reconstituted intravenously with 2 x  107 syngeneic bone marrow cells the 
same day, and used 6  wk later; (b) mice were exposed to 500  rad of gamma irradiation 
and used 2 d later. 
Treatment  with  Anti-Thy-l.2  Antibody.  Spleen  cell  suspensions  were  prepared  as  de- 
scribed above, and treated with monoclonal anti-Thy-1.2 antibody as previously described 
(10). After treatment, cells were resuspended to their initial starting volumes to prevent 
positive selection of remaining cells. 
Results 
Course of Infection  in Donor Animals.  In an initial experiment the course of the 
mycobacterial infection was followed in two groups of donor animals (Fig.  1). In 
the first group,  in which mice were originally  infected with  10 s M.  boris BCG, 
the course of infection was characterized by progressive growth of the organism 
in the spleen, followed after about  15 d  by a  gradual  reduction  in the number 
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FIGURE  1.  Growth of mycobacterial infections in donor animals. Mice were infected intra- 
venously with M.  tuberculosis (strain Erdman) or with M. bovis BCG, and the course of the 
infection in the liver (O), spleen (11), and lungs (&) followed over time. ORME  AND  COLLINS  77 
of infectious organisms in the spleen and liver. A  similar if more acute profile 
was observed in mice infected with  105 M.  tuberculosis Erdman, where bacterial 
numbers ceased to  increase by day  20  of the infection.  It  was  reasonable  to 
hypothesize, therefore, that the timing of the abridgement of bacterial prolifer- 
ation reflected the development in the host of an emerging immune response, 
and  that  therefore donor cells should  be harvested at  those times for use in 
adoptive  transfer of immunity.  It  should  also  be  noted  (with  regard  to  data 
presented below) that despite the generation of an apparent host response in the 
spleen and liver of the donor mice, evidence for a  protective response in  the 
(intravenously) infected lung was not observable for several more days. 
Demonstration  That  Adoptive  Protection  Against  Intravenous  Challenge  with  M. 
tuberculosis Requires  T  Cell-deficient Recipients.  In this series of experiments the 
growth of M.  tuberculosis  Erdman was followed over time after injection of a 
challenge inoculum into normal or T  cell-deficient mice, and was compared with 
the growth of the organism in mice infused either with T  cell-enriched spleen 
cells from Erdman-immunized mice or with similar cells from uninfected normal 
mice (Fig. 2). The results show that the infusion of ceils from immunized donors 
had no protective effect on the course of the challenge infection in the normal 
recipients, whereas they transferred significant protection against a similar chal- 
lenge infection in  those mice rendered T  cell-deficient (500  rad-irradiated or 
thymectomized [ThXB]).  This protection was quickly expressed in the spleen 
and liver, with significant resistance to the infection present by day  14;  in the 
case of the lungs, however, it was somewhat slower, a result compatible to events 
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FIGURE 2.  Evidence that infusion of T cell-enriched spleen cells from M. tuberculosis-immune 
donor mice has no effect on the course of M.  tuberculosis infection in normal recipients (top 
row), but transfers significant adoptive protection to sublethally irradiated recipients (middle) 
and to ThXB recipients (bottom). (e) Infected recipients alone, (A) recipients infused with T 
cell-enriched cells from normal animals, (ll) recipients infused with T  cell-enriched cells from 
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seen in the lungs of the donor animals. Although the transfer of T  cell-enriched 
spleen  cells from normal  donors  had  no effect on  the course of infection in 
normal  recipients,  there  was  evidence  to  suggest  that  they  may  have  been 
reconstituting the normal defenses of the T  cell-deficient mice, as evidenced by 
the expression of a minor degree of protection in these mice after 21 d. A similar 
degree of protection against the Erdman challenge infection could be transferred 
to either type of T  cell-deficient mice if donor spleen cells were obtained from 
mice immunized with BCG rather than Erdman (data not shown). 
Evidence  That Cells Which Transfer Protection Against Intravenous Challenge Are T 
Cells.  Evidence that  the protection obtained against M.  tuberculosis  challenge 
was mediated by T  cells was obtained by determining whether immune spleen 
cells from M.  tuberculosis-infected donors failed to transfer protection to T  cell- 
deficient recipients after the treatment of donor cells with antibody raised against 
the Thy-l.2 marker plus complement. The results in Fig. 3 show that treatment 
with anti-Thy-l.2 antibody plus complement completely ablated the capacity of 
the immune cells to transfer protection against the M.  tuberculosis  challenge in 
the T cell-deficient mice. This experiment thus demonstrates that passive transfer 
of protection in this model is T  cell-mediated. 
Protection of the Lung After Aerosol Infection of  M. tuberculosis: A Similar Requirement 
for a T Cell-deficient  Host.  In these experiments it was determined whether the 
passive transfer of spleen cells from BCG-immunized donors could protect the 
host  after  an  acute  aerosol  challenge  with  a  virulent  strain  (H37Rv)  of M. 
tuberculosis. Again, it was clear that adoptive protection could be transferred only 
if the recipient was rendered T  cell-deficient (Fig.  4).  However, in contrast to 
the intravenous infection model, in which protection was quickly expressed in 
the spleen and  liver,  protection against  the aerosol  infection was  not evident 
within the lungs for at least 20-25 d, after which time the course of the infection 
was characterized by  apparent  bacteriostasis,  with  no  further apparent  gross 
changes in the numbers of infectious organisms. 
In the course of these experiments it was evident that, despite the procedures 
to obtain a  nonadherent T  cell-enriched spleen cell population prior to passive 
transfer, a  contaminating residual level of BCG organisms was present in  the 
passive cell-transfer inocula. By plating suitable dilutions of these cell suspensions 
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FIGURE 3.  Evidence that donor spleen cells that adoptively transfer protection are T  cells. 
Recipients were sublethally irradiated, then infected with M.  tuberculosis.  (0) Recipients that 
received no  cells,  (ml) recipients  of T  cell-enriched immune  cells,  (l"l) immune  cells after 
treatment with antibody to Thy-l.2 plus complement, (&) immune cells treated with comple- 
ment only. ORME  AND  COLLINS  79 
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FIGURE 4.  Evidence that immune cells can adoptively protect the lungs of T  cell-deficient 
recipients. (a) Normal mice (O), normals infused with normal cells (11), normals infused with 
immune cells (i),  normais given normal cells admixed with  104 BCG (I-1). (b) Sublethally 
irradiated recipients (O), given normal cells (.),  immune cells (A), or normal cells admixed 
with 104 BCG ([]). (c) ThXB recipients (O), given normal cells (HI), or immune cells (&). In all 
cases cells were nonadherenL T  cell-enriched spleen cells and were infused within 94 h of an 
aerosol-delivered challenge with M. tuberculosis HsTRv. 
it was determined that each inoculum was contaminated with between 10 a and 
l04  viable  BCG.  It  therefore  followed that  there  was  a  possibility  that  this 
contamination  could  have  induced  some  de  novo protection  in  the  recipient 
resulting in heightened resistance to the aerosol infection. This possibility was 
unlikely in  view  of the  observation  that  inocula of immune cells  (containing 
contaminating BCG) did not confer any resistance to normal recipients, but to 
test this possibility further, normal cells were admixed with 104 BCG and infused 
into  normal or T  cell-deficient recipients (Fig.  4).  The results show that  this 
admixture had no protective effect against the aerosol infection and thus dem- 
onstrate that the observed protection of the lungs was mediated by the passive 
transfer of immune cells, rather than by the generation of acquired resistance in 
the recipients to the contaminating BCG. 
Evidence  That Protection in  the Lung Is Mediated  by T  Cells.  The experiment 
shown in Fig. 5 demonstrates that passive transfer of BCG-immune spleen cells 
into T  cell-deficient mice can adoptively protect the recipient against a progres- 
sively growing aerosol infection with M. tuberculosis. However, after treatment of 
the cell population with anti-Thy-l.2 antibody plus complement, this protective 
activity was completely ablated, demonstrating in this model that protection of 
the tuberculous lung was T  cell-mediated. 
Stability  of Transferred  Protection.  It  was  demonstrated  in  experiments  de- 
scribed above that T  cell-deficient mice exposed to a  lethal aerosol challenge 
with M.  tuberculosis could be protected by the passive transfer of immune T  cells 
regardless of whether the recipients were rendered T  cell-deficient by sublethal 
irradiation  (500  rad)  or  by  thymectomy, irradiation,  and  bone  marrow  cell 
reconstitution (ThXB). However, despite an apparent bacteriostasis ('-~ 107 viable 
organisms) in the lungs of surviving adoptively protected 500-tad recipients, it 
was clear that continued growth of the infection was occurring from time to time 
in individual animals, with a  resulting steady increase in  cumulative mortality 80  IMMUNITY  TO  MYCOBACTERIUM  TUBERCULOSIS 
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FIGURE 5.  Evidence that adoptive protection  of the lungs was mediated by T  cells. ThXB 
recipients (O) were infused with T  cell-enriched immune cells (&), immune cells treated with 
antibody to Thy-1.2 plus complement (FI), or immune cells treated with complement only (1). 
Cells were infused within 24 h of an aerosol-delivered challenge with M. tuberculosis  HsTRv. 
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FIGURE 6.  Evidence that adoptive  protection  is much more tong-lived in ThXB recipients 
than in sublethally irradiated (500 rad) recipients. These animals, plus a group of normal mice, 
were  infused  with  8  x  l0  T M.  tuberculosis-immune  T  cell-enriched  spleen  cells,  24  h  after 
aerosol-delivered  exposure  to M.  tuberculosis  HsTRv (day 0).  20 animals were tested  in each 
group. 
with  time  (Fig.  6).  In  contrast,  however,  very  little  mortality  was  observed  in 
ThXB  recipients despite similar  levels of infections in the lungs of these mice. 
These results suggest that the passive transfer of adoptive immunity in the lungs 
was apparently very much more stable in ThXB than in 500-rad recipients, and 
thus may  indicate  that mice  rendered  T  cell-deficient  by  sublethal  irradiation 
are  undergoing  adaptive  changes  which  may  interfere  with  their  subsequent 
protection and survival. 
Discussion 
This paper shows that the mouse can be adoptively protected against an acute 
M.  tuberculosis infection, after either intravenous or aerosol infection, provided 
that the infected recipient  has been  made T  cell-deficient by thymectomy  and 
gamma  irradiation  or alternatively  by sublethal  irradiation.  It  shows,  further- 
more, that the passive transfer of sensitized T  cells confers upon such recipients ORME  AND  COLLINS  81 
the ability to  control progressive growth of the M  tuberculosis challenge, and 
provides  the  first evidence that  such cells  can adoptively protect the  animal 
against an acute aerosol-delivered infection within the lungs. The results obtained 
in  the  intravenous  infection  model  confirm and  extend  the  observations  of 
Lefford (6),  who demonstrated that T  cells from the spleens of BCG-immune 
donors could adoptively transfer protection into sublethally irradiated recipients. 
This protection, which was measured as a  statistically significant difference in 
numbers of infectious organisms in the spleen 2 wk after challenge, was conferred 
equally against BCG reinfection and intravenous challenge with M.  tuberculosis 
HsTRv. 
The finding that sublethal irradiation of recipients before passive transfer of 
immune cells may facilitate the transfer of adoptive cell-mediated immunity has 
been noted elsewhere (6,  11).  It was clear in  the present study however, that 
mice given sublethal irradiation before the M.  tuberculosis challenge but which 
did not receive a passive transfer of cells had themselves started to express some 
degree of resistance to the challenge by the 3rd wk of infection. It is reasonable 
to hypothesize, therefore, that these animals were beginning to be able to re- 
express their own cell-mediated immunity to the infection. Although the nature 
of the  radiosensitive  barrier  that  prevents  the  transfer  of large  numbers  of 
immune cells into normal recipients remains unknown (12),  it is quite possible 
that  this  blocking  mechanism is  subsequently reestablished in  the  sublethally 
irradiated recipients during their recovery from exposure to this irradiation. It 
is quite possible, therefore, that any interaction between such a mechanism and 
the presence in the recipient of passively transferred immune cells may affect 
the stability or longevity of the transferred immunity. Evidence in support  of 
this possibility is provided by the observation that adoptive protection against 
the aerosol infection in the lung was achieved in the 500-rad irradiated recipients, 
but consisted of prolonged survival rather than absolute protection over a  long 
period of time. In contrast, in ThXB mice, in which there was no evidence for 
the emergence of ceil-mediated immunity to  the infection, passive transfer of 
immune ceils protected in the lungs and resulted in the long-term survival of 
these animals  (only  15%  mortality at  day  120).  It  follows that  in  models of 
chronic  tuberculosis  infection  (resulting  from  passive  transfer  of protection 
against progressive infection) the ThXB mouse should be the recipient of choice, 
in  that the expression of adoptively transferred immunity apparently remains 
stable over a long period of time. On the other hand, it is possible that the less 
stable immunity in the 500-rad recipient may serve as an appropriate model of 
the  reemergence of progressive  tuberculous  infection  in  the  lungs  that  may 
follow as  a  result  of any  interaction  between  cells  which  mediate protective 
immunity and  normal negative regulatory mechanisms. This  latter possibility 
remains to be investigated. 
It has previously been suggested that adoptive immunity could not be expressed 
within the lung (13) perhaps due to the defective migration of lymphocytes in 
this organ. The more recent findings of Lefford (14), however, and the results 
of the present study refute this suggestion, and as previously suggested (14), it is 
clear  that  adoptive  immunity to  tuberculosis  can  be  expressed  in  the  lungs 
provided  that  a  sufficiently large  inoculum of immune cells,  taken  from the 82  IMMUNITY TO  MYCOBACTERIUM TUBERCULOSIS 
donor at the height of  the primary immune response, is intravenously  transferred. 
This requirement, plus the need for T  cell-deficient recipients, and because of 
the considerable delay before protection can be detected in the aerosol-infected 
lung, may help to explain the earlier failures reported in this area (2, 3). 
It is concluded, therefore, that the expression of adoptive protection by the 
passive transfer of sensitized T  cells into M. tuberculosis-infected,  T  cell-deficient 
recipient mice may serve  as a  basic  model for the analysis of the nature and 
kinetics of the acquired immune response to aerosol-delivered and intravenous 
M. tuberculosis  infection, and may further our understanding of the development 
of immunity to  the  naturally acquired  human disease.  The  characteristics of 
sensitized T  cells  that are  acquired  in  the  host at  the  height of the  primary 
immune response  to M.  tuberculosis  are  currently under  investigation in  this 
laboratory. 
Summary 
The results of this study demonstrate that spleen cells taken from mice at the 
height of the primary immune response to intravenous infection with Mycobacte- 
rium tuberculosis  possess the capacity to transfer adoptive protection to M.  tuber- 
culosis-infected  recipients, but only if these recipients are first rendered T  cell- 
deficient, either by thymectomy and gamma irradiation, or by sublethal irradia- 
tion. A similar requirement was necessary to demonstrate the adoptive protection 
of the lungs after exposure to an acute aerosol-delivered M. tuberculosis  infection. 
In both infectious models successful adoptive immunotherapy was shown to be 
mediated  by  T  iymphocytes, which  were  acquired  in  the  donor  animals  in 
response to the immunizing infection. It is proposed that the results of this study 
may serve as a  basic model for the subsequent analysis of the nature of the T 
cell-mediated immune response to both systemic and aerogenic infections with 
M. tuberculosis. 
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